Canada Markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
125.83+1.12 (+0.90%)
At close: 04:02PM EST
125.78 -0.05 (-0.04%)
After hours: 05:06PM EST
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.69
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3142.60
52 Week Low 3105.36
50-Day Moving Average 3132.18
200-Day Moving Average 3123.20

Share Statistics

Avg Vol (3 month) 35.52M
Avg Vol (10 day) 36.51M
Shares Outstanding 51.77B
Implied Shares Outstanding 6N/A
Float 81.75B
% Held by Insiders 10.73%
% Held by Institutions 175.31%
Shares Short (Dec. 14, 2021) 49.68M
Short Ratio (Dec. 14, 2021) 41.86
Short % of Float (Dec. 14, 2021) 40.56%
Short % of Shares Outstanding (Dec. 14, 2021) 40.55%
Shares Short (prior month Nov. 14, 2021) 410.14M

Dividends & Splits

Forward Annual Dividend Rate 41.88
Forward Annual Dividend Yield 41.38%
Trailing Annual Dividend Rate 31.80
Trailing Annual Dividend Yield 31.44%
5 Year Average Dividend Yield 41.63
Payout Ratio 442.43%
Dividend Date 3Feb. 14, 2022
Ex-Dividend Date 4Jan. 12, 2022
Last Split Factor 210000:4798
Last Split Date 3Jan. 01, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 17.12%
Operating Margin (ttm)20.91%

Management Effectiveness

Return on Assets (ttm)7.74%
Return on Equity (ttm)21.86%

Income Statement

Revenue (ttm)42.31B
Revenue Per Share (ttm)23.82
Quarterly Revenue Growth (yoy)23.40%
Gross Profit (ttm)19.61B
EBITDA 12.37B
Net Income Avi to Common (ttm)7.21B
Diluted EPS (ttm)4.03
Quarterly Earnings Growth (yoy)70.50%

Balance Sheet

Total Cash (mrq)9.69B
Total Cash Per Share (mrq)5.48
Total Debt (mrq)18.4B
Total Debt/Equity (mrq)53.11
Current Ratio (mrq)1.83
Book Value Per Share (mrq)19.47

Cash Flow Statement

Operating Cash Flow (ttm)11.26B
Levered Free Cash Flow (ttm)8.13B